VC Cell Therapy

VCCT Inc. was established in 2021 by Masayo Takahashi as a member company of the Kobe Eye Center initiative. The initiative, participated by hospitals, companies, academia, and patient-case NGOs, aims to collectively deliver total care for visually impaired patients through the establishment of the Center of Excellence. VCCT’s goal is primarily to deliver regenerative cell therapy through R&D, but also to address any challenges in the healthcare system that may prevent the new therapy from becoming widely adopted and reaching patients quickly.